The FINDRISC scale as a risk assessment tool for liver fibrosis in patients with nonalcoholic fatty liver disease

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the world, which includes changes from hepatic steatosis and nonalcoholic steatohepatitis to fibrosis and cirrhosis. Attempts to find noninvasive markers of liver fibrosis have led to a variety of scales...

Full description

Bibliographic Details
Main Authors: A. S. Kuznetsova, A. I. Dolgushina, A. A. Selyanina, T. A. Sokolova, E. R. Olevskaya, V. V. Genkel
Format: Article
Language:English
Published: Endocrinology Research Centre 2023-01-01
Series:Ожирение и метаболизм
Subjects:
Online Access:https://www.omet-endojournals.ru/jour/article/view/12832